We are live on ! Find out more
SCM

Soleus Capital Management Portfolio holdings

AUM $2.47B
1-Year Est. Return 115.63%
This Fund
S&P 500
This Quarter Est. Return
+32.15%
1 Year Est. Return
+115.63%
3 Year Est. Return
+435.52%
5 Year Est. Return
+604.31%
10 Year Est. Return
–
AUM
$901M
AUM Growth
-$183M
Cap. Flow
-$318M
Cap. Flow %
-35.32%
Top 10 Hldgs %
45.07%
Holding
107
New
16
Increased
16
Reduced
34
Closed
34

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$25.1M
2
PEN icon
Penumbra
PEN
+$17.6M
3
IDYA icon
IDEAYA Biosciences
IDYA
+$16.9M
4
GSK icon
GSK
GSK
+$12M
5
NUVL
Nuvalent
NUVL
+$10.4M

Top Sells

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$26M
2
ACLX
Arcellx
ACLX
+$21.9M
3
PODD icon
Insulet
PODD
+$20.4M
4
EOLS icon
Evolus
EOLS
+$19M
5
CRL icon
Charles River Laboratories
CRL
+$18.8M

Sector Composition

Rank Sector Weight
1 Healthcare 99.95%
2 Consumer Staples 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TARS icon
101
Tarsus Pharmaceuticals
TARS
$2.85B
– –
-250,000
Closed -$4.44M
URGN icon
102
UroGen Pharma
URGN
$2.22B
– –
-372,000
Closed -$5.21M
XBI icon
103
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.1B
– –
-1,250,000
Closed -$91.3M
XLO icon
104
Xilio Therapeutics
XLO
$61M
– –
-16,210
Closed -$479K
WHWK
105
Whitehawk Therapeutics
WHWK
$232M
– –
-333,227
Closed -$1.61M
ALPN
106
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-88,073
Closed -$1.01M
KRTX
107
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-6,440
Closed -$1.09M
1 2 3 4
5

Similar funds

TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
Q
QVR San Francisco, California $2.49B AUM 48.58% 1-Year Est. Return
SIM
Stratos Investment Management Beachwood, Ohio $2.49B AUM 17.24% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return

Soleus Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Soleus Capital Management held 107 positions worth $901M, down 17% from $1.08B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Soleus Capital Management withdrew a net $318M in Q4 2023, closing 34 positions and reducing 34 holdings. Its most notable exit was Insulet, an estimated $20.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 90% a quarter earlier, followed by Consumer Staples.

Against the trend, Soleus Capital Management opened a new position in HCA Healthcare worth $27.5M.

  • Soleus Capital Management's largest Q4 2023 buy was HCA Healthcare: 101,500 shares worth $27.5M.
  • Soleus Capital Management added most to GSK in Q4 2023, an estimated $12M increase.
  • Soleus Capital Management's biggest Q4 2023 reduction was TG Therapeutics, cutting an estimated $26M.
  • Soleus Capital Management fully exited Insulet in Q4 2023, selling an estimated $20.4M.
  • Soleus Capital Management's ten largest holdings make up 45% of its $901M portfolio in Q4 2023.
  • Soleus Capital Management opened 16 new positions and closed 34 in Q4 2023.
  • Soleus Capital Management's portfolio value fell 17% quarter-over-quarter to $901M.

Based on Soleus Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.